4//SEC Filing
Kucinski Keith A 4
Accession 0001493152-20-011533
CIK 0001582554other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:30 PM ET
Size
5.7 KB
Accession
0001493152-20-011533
Insider Transaction Report
Form 4
Kucinski Keith A
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2020-06-17+175,000→ 175,000 totalExercise: $0.81Exp: 2030-06-16→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the "Milestone"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001763405
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:30 PM ET
- Size
- 5.7 KB